Working...
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01724021
Brief Title: A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a

First Submitted : November 5, 2012
First Submitted that Met QC Criteria : November 6, 2012
First Posted : November 9, 2012 (Estimate)

Results First Submitted : May 3, 2016
Results First Submitted that Met QC Criteria : July 19, 2016
Results First Posted : August 29, 2016 (Estimate)

Last Update Submitted that Met QC Criteria : December 19, 2017
Last Update Posted : January 23, 2018